Related Experiment Video
Updated: Apr 19, 2026

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Comorbidity in pediatric bipolar disorder: prevalence, clinical impact, etiology and treatment
Álvaro Frías1, Cárol Palma1, Núria Farriols1
1FPCEE Blanquerna, University of Ramon-Llull, Císterst 34, 08022 Barcelona, Spain; Adult Outpatient Mental Health Center, Hospital of Mataró, Mataró, Spain.
Insights
Pediatric bipolar disorder (PBD) frequently co-occurs with other conditions like anxiety and ADHD, negatively impacting youth. Effective treatments are emerging for these comorbidities.
Area of Science:
- Child and Adolescent Psychiatry
- Neurodevelopmental Disorders
- Mental Health Research
Background:
- Pediatric bipolar disorder (PBD) research increasingly highlights significant comorbidity.
- Understanding these co-occurring conditions is crucial for effective PBD management.
Purpose of the Study:
- To systematically review the prevalence, clinical impact, etiology, and treatment of disorders comorbid with PBD.
- To synthesize current evidence on the interplay between PBD and other psychiatric conditions in youth.
Main Methods:
- A comprehensive literature search was conducted from 1990 to August 2014.
- 167 studies met the inclusion criteria for the systematic review.
Main Results:
- Anxiety disorders (54%), ADHD (48%), disruptive behavior disorders (31%), and substance use disorders (31%) are highly prevalent comorbidities in PBD.
- Comorbid ADHD and anxiety disorders worsen PBD symptoms, neurocognition, and overall functioning.
- Stimulants and atomoxetine show efficacy as adjunctive treatments for ADHD in PBD; mood stabilizers and SGAs may benefit other comorbidities.
Conclusions:
- High comorbidity in PBD has detrimental clinical effects, with diverse etiological pathways.
- Further research is needed on the etiology and treatment of PBD comorbidities, particularly pervasive developmental and anxiety disorders.
- Epidemiologic studies are essential to refine understanding and avoid nosological artifacts.
Background:
Research on pediatric bipolar disorder (PBD) is providing a plethora of empirical findings regarding its comorbidity. We addressed this question through a systematic review concerning the prevalence, clinical impact, etiology and treatment of main comorbid disorders involved.
Method:
A comprehensive database search was performed from 1990 to August 2014. Overall, 167 studies fulfilled the inclusion criteria.
Results:
Bipolar youth tend to suffer from comorbid disorders, with highest weighted mean prevalence rate arising from anxiety disorders (54%), followed by attention deficit hyperactivity disorder (ADHD) (48%), disruptive behavior disorders (31%), and substance use disorders (SUD) (31%). Furthermore, evidence indicates that ADHD and anxiety disorders negatively affect the symptomatology, neurocognitive profile, clinical course and the global functioning of PBD. Likewise, several theories have been posited to explain comorbidity rates in PBD, specifically common risk factors, one disorder being a risk factor for the other and nosological artefacts. Lastly, randomized controlled trials highlight a stronger therapeutic response to stimulants and atomoxetine (vs. placebo) as adjunctive interventions for comorbid ADHD symptoms. In addition, research focused on the treatment of other comorbid disorders postulates some benefits from mood stabilizers and/or SGA.
Limitations:
Epidemiologic follow-up studies are needed to avoid the risk of nosological artefacts. Likewise, more research is needed on pervasive developmental disorders and anxiety disorders, especially regarding their etiology and treatment.
Conclusions:
Psychiatric comorbidity is highly prevalent and is associated with a deleterious clinical effect on pediatric bipolarity. Different etiological pathways may explain the presence of these comorbid disorders among bipolar youth. Standardized treatments are providing ongoing data regarding their effectiveness for these comorbidities among bipolar youth.
More Related Videos
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
07:57A New Method for Inducing a Depression-Like Behavior in Rats
Published on: February 22, 2018
Related Concept Videos
Bipolar Disorder
Mania and Antimanic Drugs: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Bulimia Nervosa
Diagnostic and Statistical Manual of Mental Disorders (DSM)